Acrivon Therapeutics Inc (NASDAQ:ACRV) Has Recovered -81.53% To Date, But An Additional -652.59% Is Possible.
In last trading session, Acrivon Therapeutics Inc (NASDAQ:ACRV) saw 0.69 million shares changing hands with its beta currently measuring 1.52. Company’s recent per share price